Skip to content

Clinical trials

Observational trials in Taiwan with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Status: Unknown status Country / region: Taiwan Clear all

1,171 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
200211
200316
200437
200585
200630
200724
200850
200957
201086
201189
201252
201339
201450
201547
201643
201747
201860
201976
202066
202161
202256
202345
202420

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status1,171

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital607
Chang Gung Memorial Hospital117
China Medical University Hospital58
Taipei Veterans General Hospital, Taiwan54
Far Eastern Memorial Hospital53
Taipei Medical University WanFang Hospital53
Taichung Veterans General Hospital22
Kaohsiung Medical University Chung-Ho Memorial Hospital21
National Cheng-Kung University Hospital17
National Health Research Institutes, Taiwan11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke27
Carcinoma, Hepatocellular24
Diabetes Mellitus24
Breast Neoplasms22
Neoplasms22
Lung Neoplasms20
Sepsis16
Metabolic Syndrome14
Neoplastic Cells, Circulating14
Carcinoma, Non-Small-Cell Lung13

Trials

Showing 1 to 25 of 1,171. Each trial links to its page on Pharma Observatory.

1,071 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.